{"id":"https://openalex.org/W2338595463","doi":"https://doi.org/10.1093/neuonc/nov206.07","title":"ATCT-07PHASE 2 STUDY OF MEDI-575, AN ANTI-PLATELET-DERIVED GROWTH FACTOR-\u03b1 ANTIBODY, IN PATIENTS WITH RECURRENT GLIOBLASTOMA","display_name":"ATCT-07PHASE 2 STUDY OF MEDI-575, AN ANTI-PLATELET-DERIVED GROWTH FACTOR-\u03b1 ANTIBODY, IN PATIENTS WITH RECURRENT GLIOBLASTOMA","publication_year":2015,"publication_date":"2015-11-01","ids":{"openalex":"https://openalex.org/W2338595463","doi":"https://doi.org/10.1093/neuonc/nov206.07","mag":"2338595463"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/nov206.07","doi":"https://doi.org/10.1093/neuonc/nov206.07","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nov206.07","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4638558","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068495908","display_name":"Surasak Phuphanich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surasak Phuphanich","raw_affiliation_strings":["University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029952866","display_name":"Jeffrey J. Raizer","orcid":"https://orcid.org/0009-0003-8469-2509","observed_orcids":["https://orcid.org/0009-0003-8469-2509"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Raizer","raw_affiliation_strings":["Johnnie L. Cochran Jr. Brain Tumor Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnnie L. Cochran Jr. Brain Tumor Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028023803","display_name":"Marc Charles Chamberlain","orcid":"https://orcid.org/0009-0009-5285-2807","observed_orcids":["https://orcid.org/0009-0009-5285-2807","https://orcid.org/0000-0002-1613-1123"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Chamberlain","raw_affiliation_strings":["Northwestern Brain Tumor Institute, Northwestern University, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern Brain Tumor Institute, Northwestern University, Chicago, IL, USA","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079827515","display_name":"Paola Canelos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paola Canelos","raw_affiliation_strings":["MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110048076","display_name":"Rajesh Narwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajesh Narwal","raw_affiliation_strings":["MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103357633","display_name":"Shengyan Hong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shengyan Hong","raw_affiliation_strings":["MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036095802","display_name":"Robert Miday","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Miday","raw_affiliation_strings":["MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008620511","display_name":"Minal Nade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minal Nade","raw_affiliation_strings":["MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031055498","display_name":"Kevin H. Laubscher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Laubscher","raw_affiliation_strings":["MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18837419,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"suppl 5","first_page":"v2.3","last_page":"v2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pdgf-receptor-alpha","display_name":"PDGF receptor alpha","score":0.640999972820282},{"id":"https://openalex.org/keywords/platelet-derived-growth-factor","display_name":"platelet-derived growth factor","score":0.7799999713897705},{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.9520000219345093},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.8700000047683716},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9089999794960022},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8529999852180481},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.699999988079071},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.6269999742507935},{"id":"https://openalex.org/keywords/hydrocephalus","display_name":"hydrocephalus","score":0.5730000138282776},{"id":"https://openalex.org/keywords/convulsions","display_name":"convulsions","score":0.656000018119812},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.3400000035762787}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8484538793563843},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6863893270492554},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6645843386650085},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6014120578765869},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6004633903503418},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5826563835144043},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.4578621983528137},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4537624716758728},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4482479691505432},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4209098815917969},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3333190381526947},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3174295723438263}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/nov206.07","doi":"https://doi.org/10.1093/neuonc/nov206.07","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nov206.07","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4638558","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4638558","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4638558","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4638558","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1843891279","https://openalex.org/W1858161324","https://openalex.org/W1965157625","https://openalex.org/W2007540726","https://openalex.org/W2028556467","https://openalex.org/W2052858979","https://openalex.org/W2074343604","https://openalex.org/W2107731685","https://openalex.org/W2111718329","https://openalex.org/W2122436079","https://openalex.org/W2127445947","https://openalex.org/W2131403504","https://openalex.org/W2132697290","https://openalex.org/W2140301591","https://openalex.org/W2154974088","https://openalex.org/W2158681922","https://openalex.org/W2162643152","https://openalex.org/W2164279223","https://openalex.org/W2170429308"],"related_works":["https://openalex.org/W2549166928","https://openalex.org/W2067703011","https://openalex.org/W1023148064","https://openalex.org/W2122436079","https://openalex.org/W2395017297","https://openalex.org/W2602584329","https://openalex.org/W2984540094","https://openalex.org/W2590992976","https://openalex.org/W2229066723","https://openalex.org/W188439881"],"abstract_inverted_index":{"BACKGROUND:":[0],"Altered":[1],"expression":[2],"of":[3,9,20,56,135],"platelet-derived":[4],"growth":[5],"factor-\u03b1":[6],"(PDGF-\u03b1)":[7],"and":[8,54,71,120,144,146,154,220,236,242],"the":[10,18,40,52,264],"PDGF-\u03b1":[11],"receptor":[12],"(PDGFR-\u03b1)":[13],"has":[14],"been":[15],"implicated":[16],"in":[17,58,106,245],"development":[19],"glioblastoma":[21],"(GB).":[22],"MEDI-575,":[23],"an":[24],"immunoglobulin":[25],"G2\u03ba":[26],"(IgG2\u03ba)":[27],"monoclonal":[28],"antibody,":[29],"selectively":[30],"binds":[31],"to":[32,257,271],"PDGFR-\u03b1":[33],"with":[34,39,60,64,279,292],"high":[35],"specificity,":[36],"without":[37],"cross-reacting":[38],"PDGF-\u03b2":[41],"receptor.":[42],"METHODS:":[43],"A":[44],"phase":[45],"2,":[46],"multicenter,":[47],"single-arm,":[48],"open-label":[49],"study":[50],"evaluated":[51],"efficacy":[53],"safety":[55],"MEDI-575":[57,78,255,272,275,283],"patients":[59,124,136,173,225,252,261,290],"recurrent":[61],"GB.":[62],"Adults":[63],"a":[65],"first":[66],"recurrence":[67],"following":[68],"surgery,":[69],"temozolomide,":[70],"radiation":[72],"therapy":[73],"were":[74,137,140,169,200,209,248],"eligible.":[75],"Patients":[76],"received":[77,125],"25":[79],"mg/kg":[80],"intravenously":[81],"over":[82],"60":[83],"minutes":[84],"every":[85],"21":[86],"days":[87],"until":[88],"disease":[89,176],"progression":[90],"or":[91,166],"unacceptable":[92],"toxicity.":[93],"The":[94,202],"primary":[95],"end":[96,112],"point":[97],"was":[98,129,158,183,191,268,276],"6-month":[99],"progression-free":[100],"survival":[101,118],"(PFS-6)":[102],"per":[103],"Response":[104],"Assessment":[105],"Neuro-Oncology":[107],"Working":[108],"Group":[109],"criteria;":[110],"secondary":[111],"points":[113],"included":[114],"response":[115],"rate,":[116],"overall":[117],"(OS),":[119],"safety/tolerability.":[121],"RESULTS:":[122],"Fifty-six":[123],"MEDI-575.":[126],"Median":[127,181],"age":[128],"56.5":[130],"years":[131],"(range,":[132],"23-79),":[133],"66%":[134,139],"male,":[138],"aged":[141],"\u226565":[142],"years,":[143],"46%":[145],"55%":[147],"had":[148,174,284],"baseline":[149],"ECOG":[150],"performance":[151],"status":[152],"0":[153],"1,":[155],"respectively.":[156],"PFS-6":[157,286],"15.4%":[159],"(90%":[160,186,194],"confidence":[161],"interval:":[162],"8.1-24.9).":[163],"No":[164,197],"complete":[165],"partial":[167],"responses":[168],"observed;":[170],"23":[171],"(41%)":[172],"stable":[175],"as":[177],"their":[178],"best":[179],"response.":[180],"PFS":[182],"1.4":[184],"months":[185,193],"CI:":[187,195],"1.4-1.8);":[188],"median":[189],"OS":[190],"9.7":[192],"6.5-11.8).":[196],"dose-limiting":[198,281],"toxicities":[199],"observed.":[201],"most":[203],"common":[204],"treatment-related":[205],"adverse":[206,258],"events":[207],"(AEs)":[208],"diarrhea":[210],"(16%),":[211],"nausea":[212],"(13%),":[213,215],"fatigue":[214],"tinnitus":[216],"(4%),":[217,219,235],"asthenia":[218],"dizziness":[221],"(4%).":[222],"Seventeen":[223],"(30%)":[224],"experienced":[226],"serious":[227],"AEs,":[228],"including":[229],"convulsion":[230],"(9%),":[231],"hydrocephalus":[232],"(5%),":[233],"pneumonia":[234],"fall":[237,243],"(4%);":[238],"only":[239],"headache,":[240],"somnolence,":[241],"(all":[244],"1":[246],"patient)":[247],"considered":[249,269],"treatment-related.":[250],"Seven":[251],"(13%)":[253],"discontinued":[254],"due":[256],"events.":[259],"Thirty":[260],"died":[262],"during":[263],"study;":[265],"no":[266,280],"death":[267],"related":[270],"treatment.":[273],"CONCLUSIONS:":[274],"well":[277],"tolerated,":[278],"toxicities.":[282],"similar":[285],"rates":[287],"versus":[288],"historical":[289],"treated":[291],"chemotherapy.":[293]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}